The replication enhancer crtS depends on transcription factor Lrp for modulating binding of initiator RctB to ori2 of Vibrio cholerae
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkad1111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Alexander Doan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Basic Research Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Bacterial Proteins, DNA Replication, Vibrio cholerae, Leucine-Responsive Regulatory Protein. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Replication of Vibrio cholerae chromosome 2 (Chr2) initiates when the Chr1 locus, crtS (Chr2 replication triggering site) duplicates. The site binds the Chr2 initiator, RctB, and the binding increases when crtS is complexed with the transcription factor, Lrp. How Lrp increases the RctB binding and how RctB is subsequently activated for initiation by the crtS-Lrp complex remain unclear. Here we show that Lrp bends crtS DNA and possibly contacts RctB, acts that commonly promote DNA-protein interactions. To understand how the crtS-Lrp complex enhances replication, we isolated Tn-insertion and point mutants of RctB, selecting for retention of initiator activity without crtS. Nearly all mutants (42/44) still responded to crtS for enhancing replication, exclusively in an Lrp-dependent manner. The results suggest that the Lrp-crtS controls either an essential function or more than one function of RctB. Indeed, crtS modulates two kinds of RctB binding to the origin of Chr2, ori2, both of which we find to be Lrp-dependent. Some point mutants of RctB that are optimally modulated for ori2 binding without crtS still remained responsive to crtS and Lrp for replication enhancement. We infer that crtS-Lrp functions as a unit, which has an overarching role, beyond controlling initiator binding to ori2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Basic Research Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Collaborative Protein Technology Resource, OSTP, Center for Cancer Research, NCI, NIH, Bethesda, MD 20892, USA.
- College of Medicine, Mohammed Bin Rashid University, Dubai, UAE.
ORCID-Profile: Revathy Ramachandran
Förderung
- NCI NIH HHS
- NIH HHS
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Doan, A., Chatterjee, S., Kothapalli, R., Khan, Z., Sen, S., Kedei, N., Jha, J. K., Chattoraj, D. K., & Ramachandran, R. (2024). The replication enhancer crtS depends on transcription factor Lrp for modulating binding of initiator RctB to ori2 of Vibrio cholerae. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad1111
Vancouver
Doan A, Chatterjee S, Kothapalli R, Khan Z, Sen S, Kedei N, et al. The replication enhancer crtS depends on transcription factor Lrp for modulating binding of initiator RctB to ori2 of Vibrio cholerae. Nucleic Acids Research. 2024. doi:10.1093/nar/gkad1111
BibTeX
@article{Doan2024,
author = {Doan, Alexander and Chatterjee, Soniya and Kothapalli, Roopa and Khan, Zaki and Sen, Shaanit and Kedei, Noemi and Jha, Jyoti K and Chattoraj, Dhruba K and Ramachandran, Revathy},
title = {The replication enhancer crtS depends on transcription factor Lrp for modulating binding of initiator RctB to ori2 of Vibrio cholerae},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkad1111}
}
EUVIMED